Author Correction: Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin

Acta Pharmacol Sin. 2022 Jul;43(7):1881. doi: 10.1038/s41401-021-00834-x.
No abstract available

Publication types

  • Published Erratum